Professor Michael Berk is an NHMRC Senior Principal Research Fellow and Alfred Deakin Chair of Psychiatry at Deakin University and Barwon Health, where he heads the IMPACT Strategic Research Centre. He holds an Honorary position at both Melbourne and Monash University and is a highly cited researcher with over 800 published papers predominantly in mood disorders. His major interests are in the discovery and implementation of novel therapies, and risk factors and prevention of psychiatric disorders.
• Study results show an effect of NAC only in people with severe depression.
• NAC has no effect on idiopathic pulmonary fibrosis but does improve the quality of life for patients.
• Complex 1 of the mitochondrial electron transfer chain is dramatically down-regulated in bipolar disorder.
Full article: https://psychscenehub.com/video/nac-and-mitochondrial-abnormalities-by-professor-michael-berk/